Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "bicarbonate gradient" refers to the difference in bicarbonate ion concentration across a biological membrane. This gradient is essential for acid–base homeostasis, cellular pH regulation, and transport of CO₂ waste, functioning largely via bicarbonate transporters (such as SLC4 and SLC26 family members) and enzymes like carbonic anhydrase, which are the true molecular targets in therapeutic contexts[1][5][6][8][9]. Disrupted bicarbonate gradients, typically due to dysfunction of these proteins, underlie various diseases including some forms of renal tubular acidosis and cancer. Therapies and diagnostics focus on modulating or assessing the activity and function of the proteins responsible for generating and maintaining these gradients, not the gradient itself.
Not applicable to the gradient itself; relevant mechanisms include: Inhibition of bicarbonate transporters; Inhibition of carbonic anhydrases, which modulate bicarbonate gradients
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bicarbonate gradient.